Zobrazeno 1 - 10
of 225
pro vyhledávání: '"JS Carroll"'
Autor:
Z Li, A Bahreini, KM Levine, P Wang, N Tasdemir, MA Montanez, P Sundd, CT Wallace, SC Watkins, D Chu, BH Park, W Hou, MS Mooring, L Zhu, GC Tseng, JS Carroll, JM Atkinson, AV Lee, S Oesterreich
Publikováno v:
Cancer Research. 79:P2-01
Background: Estrogen receptor alpha (ERα/ESR1) is mutated in 30-40% of endocrine resistant ER+ breast cancer. These mutations, primarily located in the ligand binding domain, are associated with worse outcome in patients, and preclinical studies hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c42ee4900eb1e9830354da7392c9400c
https://doi.org/10.1158/1538-7445.sabcs18-p2-01-09
https://doi.org/10.1158/1538-7445.sabcs18-p2-01-09
Autor:
DiCiaccio B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Seehawer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Patmanidis A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bui T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Foidart P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Nishida J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., D'Santos CS; Cambridge Research Institute, University of Cambridge, Cambridge, UK., Papachristou EK; Cambridge Research Institute, University of Cambridge, Cambridge, UK., Papanastasiou M; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA., Reiter AH; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Jiang Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Huang XY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Simeonov A; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Kales SC; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Rai G; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Lal-Nag M; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Jadhav A; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Carroll JS; Cambridge Research Institute, University of Cambridge, Cambridge, UK., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address: kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2024 Dec 24; Vol. 43 (12), pp. 114991. Date of Electronic Publication: 2024 Nov 20.
Autor:
Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Chen F; School of Medicine, Tsinghua University, Beijing, China.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Chen L; Computational Biology Department, Carnegie Mellon University, Pittsburgh, PA, USA., Liu J; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Tseng D; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Hadi F; AstraZeneca, The Discovery Centre, Biomedical Campus, Cambridge, UK., Omarjee S; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kishore K; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kent J; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kirkpatrick J; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., D'Santos C; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Lawson M; AstraZeneca, The Discovery Centre, Biomedical Campus, Cambridge, UK., Gertz J; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA., Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McDonnell DP; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Carroll JS; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA., Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. leeav@upmc.edu.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA. leeav@upmc.edu.; Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, PA, USA. leeav@upmc.edu.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Dec 19; Vol. 10 (1), pp. 106. Date of Electronic Publication: 2024 Dec 19.
Autor:
Martin PL; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom., Pérez-Areales FJ; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom., Rao SV; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, CH2 ORE, United Kingdom., Walsh SJ; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom., Carroll JS; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, CH2 ORE, United Kingdom., Spring DR; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.
Publikováno v:
ChemMedChem [ChemMedChem] 2024 Aug 19; Vol. 19 (16), pp. e202400269. Date of Electronic Publication: 2024 Jun 20.
Autor:
Ramachandran R; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Ibragimova S; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Woods LM; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK., AlHouqani T; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Gomez RL; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Simeoni F; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK., Hachim MY; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Somervaille TCP; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK., Philpott A; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Ali FR; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Publikováno v:
IScience [iScience] 2024 Jul 14; Vol. 27 (8), pp. 110500. Date of Electronic Publication: 2024 Jul 14 (Print Publication: 2024).
Autor:
Walther R; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, UK., Park M; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, UK., Ashman N; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, UK., Welch M; Department of Biochemistry, University of Cambridge, CB2 1QW Cambridge, UK., Carroll JS; Cancer Research UK Cambridge Institute, Robinson Way, CB2 0RE Cambridge, UK., Spring DR; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, UK.
Publikováno v:
Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2024 Jul 04; Vol. 60 (55), pp. 7025-7028. Date of Electronic Publication: 2024 Jul 04.
Autor:
Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Chen F; School of Medicine, Tsinghua University, Beijing, China.; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh PA, USA., Chen L; Computational Biology Department, Carnegie Mellon University, Pittsburgh PA, USA., Liu J; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh PA, USA.; Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Tseng D; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh PA, USA., Hadi F; AstraZeneca, UK, London, UK., Omarjee S; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kishore K; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kent J; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Kirkpatrick J; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., D'Santos C; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Lawson M; AstraZeneca, UK, London, UK., Gertz J; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA., Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McDonnell DP; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Carroll JS; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, UK., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh PA, USA., Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh PA, USA.; Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.
Autor:
Shawcroft J; School of Family Life, Brigham Young University, USA., Gale M; School of Family Life, Brigham Young University, USA., Coyne SM; School of Family Life, Brigham Young University, USA., Twenge JM; Department of Psychology, San Diego State University, USA., Carroll JS; School of Family Life, Brigham Young University, USA., Wilcox WB; Department of Sociology, University of Virginia, USA., James S; School of Family Life, Brigham Young University, USA.
Publikováno v:
Heliyon [Heliyon] 2024 Apr 26; Vol. 10 (9), pp. e30236. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024).
Autor:
Hosseinzadeh L; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Kikhtyak Z; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Laven-Law G; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Pederson SM; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Puiu CG; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., D'Santos CS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Lim E; Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia. theresa.hickey@adelaide.edu.au.
Publikováno v:
Genome biology [Genome Biol] 2024 Feb 05; Vol. 25 (1), pp. 44. Date of Electronic Publication: 2024 Feb 05.
Autor:
Ferguson KM; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK., Gillen SL; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK., Chaytor L; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK., Poon E; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK., Marcos D; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK., Gomez RL; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Healthcare City, P.O. Box 505055, Dubai, United Arab Emirates., Woods LM; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK., Mykhaylechko L; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK., Elfari L; Wellcome-MRC Cambridge Stem Cell Institute Advanced Imaging Facility, Cambridge CB2 0AW, UK., Martins da Costa B; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK., Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Chesler L; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK., Ali FR; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Healthcare City, P.O. Box 505055, Dubai, United Arab Emirates., Philpott A; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK. Electronic address: ap113@cam.ac.uk.
Publikováno v:
Developmental cell [Dev Cell] 2023 Oct 09; Vol. 58 (19), pp. 1967-1982.e8. Date of Electronic Publication: 2023 Sep 20.